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Apoptotic nuclear morphological change without DNA
fragmentation
Hideki Sakahira*†, Masato Enari*‡, Yoshiyuki Ohsawa§, Yasuo Uchiyama§
and Shigekazu Nagata*†
Apoptosis is characterized morphologically by
condensation and fragmentation of nuclei and cells and
biochemically by fragmentation of chromosomal DNA
into nucleosomal units [1]. CAD, also known as CPAN or
DFF-40, is a DNase that can be activated by caspases
[2–6]. CAD is complexed with its inhibitor, ICAD, in
growing, non-apoptotic cells [2,7]. Caspases that are
activated by apoptotic stimuli [8] cleave ICAD. CAD, thus
released from ICAD, digests chromosomal DNA into
nucleosomal units [2,3]. Here, we examine whether
nuclear morphological changes induced by apoptotic
stimuli are caused by the degradation of chromosomal
DNA. Human T-cell lymphoma Jurkat cells, as well as
their transformants expressing caspase-resistant ICAD,
were treated with staurosporine. The chromosomal DNA
in Jurkat cells underwent fragmentation into
nucleosomal units, which was preceded by large-scale
chromatin fragmentation (50–200 kb). The chromosomal
DNA in cells expressing caspase-resistant ICAD
remained intact after treatment with staurosporine but
their chromatin condensed as found in parental Jurkat
cells. These results indicate that large-scale chromatin
fragmentation and nucleosomal DNA fragmentation are
caused by an ICAD-inhibitable DNase, most probably
CAD, whereas chromatin condensation during apoptosis
is controlled, at least in part, independently from the
degradation of chromosomal DNA.
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Results and discussion
Treatment of human Jurkat cells with staurosporine acti-
vates caspases to promote the apoptotic program. One of
the caspases activated during apoptosis is caspase 3, which
cleaves ICAD at residues Asp117 and Asp224 [3,9]. This
cleavage allows the release of CAD from ICAD, and CAD
then cleaves chromosomal DNA. Replacement of the
aspartic acid residues by glutamic acid renders ICAD
resistant to caspases without affecting its ability to inhibit
the DNase activity of CAD [3]. 
We have previously established Jurkat cell transformants
(JILdm) that express a mutant form of mouse ICAD,
which carries glutamic acid in place of residues Asp117
and Asp224 [3,9]. When Jurkat cells and JILdm cells were
treated with 10 µM staurosporine, both cell lines died
quickly and more than 80% of cells became Annexin-V-
positive within 2 hours ([3]; data not shown). As shown in
Figure 1a, the chromosomal DNA of Jurkat cells quickly
underwent extensive fragmentation. Most of the chromo-
somal DNA degraded into nucleosomal units within
2 hours. This process was caspase-dependent because pre-
incubation of Jurkat cells with a broad caspase inhibitor,
zVAD-fmk, completely prevented the DNA fragmenta-
tion. In contrast, JILdm cells expressing the caspase-resis-
tant ICAD were resistant to the staurosporine-induced
DNA fragmentation. Western-blot analysis indicated that
the endogenous ICAD in Jurkat and JILdm cells was
cleaved within 2 hours, whereas the mutant ICAD in
JILdm cells remained intact for at least 3 hours (data not
shown). Large-scale chromatin fragmentation is known to
precede the nucleosomal fragmentation of chromosomal
DNA during apoptosis [10,11]. To examine whether CAD
is involved in the large-scale chromatin fragmentation,
chromosomal DNA in Jurkat and JILdm cells was ana-
lyzed by pulse-field gel electrophoresis. As shown in
Figure 1b, the chromosomal DNA of Jurkat cells degraded
within 1 hour, showing broad smearing bands with a peak
at about 50 kb. The DNA fragments became smaller as
Jurkat cells were incubated for longer periods of time with
staurosporine. This large-scale chromatin degradation was
not observed if the cells were pre-incubated with
z-VAD-fmk. In contrast, treatment of JILdm cells with
staurosporine did not cause large-scale chromatin degrada-
tion and the chromosomal DNA remained intact. 
The morphology of the dying cells was then observed by
electron microscopy. As shown in Figure 2a, when Jurkat
cells were treated with staurosporine, chromatin con-
densed near the nuclear periphery within 1 hour. The
condensed chromatin was fragmented at later time points
and after a 3 hour incubation with staurosporine, all cells
carried the fragmented and condensed nuclei. If the cells
were pre-incubated with the caspase inhibitor, stauro-
sporine caused a slight change in nuclear morphology but
no condensation and fragmentation of nuclei was observed
(Figure 2e). Staurosporine also induced morphological
changes of nuclei in JILdm cells. As shown in Figure 2g,
the chromatin of JILdm cells condensed near the nuclear
periphery within 1 hour. A difference from that observed
in Jurkat cells was that the condensed chromatin in JILdm
cells remained near the nuclear periphery and no clear
fragmentation of the condensed nuclei occurred even after
a 3 hour incubation with staurosporine (Figure 2i). The
condensation of nuclei in JILdm cells was also blocked by
a caspase inhibitor (Figure 2j).
In this report, we have shown that the staurosporine-
induced large-scale chromatin fragmentation, as well as the
nucleosomal DNA fragmentation, depends on caspase
activation and can be inhibited by ICAD. These results
suggest that both large-scale chromatin fragmentation and
nucleosomal DNA fragmentation are caused by an ICAD-
inhibitable DNase, probably CAD. Chromatin periodically
attaches to the nuclear scaffold to form a series of 30–50 kb
loops [12]. Given that the scaffold-attachment regions are
more sensitive to nuclease than other regions [13], the acti-
vated CAD first cleaves DNA at this point and produces
large-scale chromatin fragmentation. This unpacks the
chromatin structure and CAD gains access to nucleosomes
and causes nucleosomal DNA fragmentation. Susin et al.
[14] recently identified AIF (apoptosis-inducing factor),
which is released from mitochondria. AIF was proposed to
enter nuclei to activate a DNase(s) that causes large-scale
chromatin fragmentation but not nucleosomal fragmenta-
tion in a caspase-independent manner. Although it is very
difficult to integrate these results into our model, our
results indicate that the DNase activated by AIF should
be inhibitable by ICAD. 
We have shown that the apoptotic chromatin condensation
could occur without any DNA fragmentation. This was
also observed with Fas-induced apoptosis in Fas-express-
ing murine WR19L cells: treatment of the cells expressing
the non-cleavable ICAD mutant with agonistic anti-Fas
antibody caused nuclear morphological changes but not
DNA fragmentation. Recently, Liu et al. [5] reported that
CAD is responsible not only for DNA fragmentation but
also for the morphological changes in nuclei. We also
observed a similar result using a cell-free system — when
isolated nuclei were incubated with purified CAD, the
chromosomal DNA was degraded and nuclei condensed
and fragmented (unpublished observations). We might
thus conclude that two different pathways can lead to
nuclear morphological changes during apoptosis, one
caused by CAD-induced DNA fragmentation and another
that does not involve DNA degradation. The stauro-
sporine-induced morphological changes of nuclei were
inhibited by a caspase inhibitor, suggesting that the other
factor(s) responsible for the chromatin condensation is a
caspase or a molecule downstream of the caspase cascade.
Caspase 6 is known to cleave nuclear lamins and its
involvement in nuclear morphological changes has been
suggested [15]. Incubation of nuclei with caspase 6 or with
a cocktail containing eight different caspases (caspases
1–8), however, did not cause morphological changes (data
not shown). On the other hand, Samejima et al. [16] pre-
pared apoptotic extracts from chicken DU249 cells and
found an activity that causes morphological changes in
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Figure 1
Nucleosomal DNA fragmentation and large-scale chromatin
fragmentation. Jurkat cells (lanes 1–5) and JILdm cells (lanes 6–10)
were treated at 37°C with 10 µM staurosporine for 0 h (lanes 1,6),
1 h (lanes 2,7), 2 h (lanes 3,8) and 3 h (lanes 4,5,9,10). In lanes 5
and 10, the cells were pre-incubated at 37°C for 1 h with 0.5 mM
zVAD-fmk before being incubated with staurosporine.
(a) Nucleosomal DNA fragmentation. After treatment with
staurosporine, chromosomal DNA (corresponding to 1.2 × 105 cells
per lane) was isolated and analyzed by electrophoresis on a 1.5%
agarose gel. Molecular weight markers (in kb) are indicated to the
left. (b) Large-scale chromatin fragmentation. After treatment with
staurosporine, the chromosomal DNA (corresponding to 2.5 × 105
cells per lane) was analyzed by pulse-field gel electrophoresis on a
1.0% agarose gel.
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nuclei. This activity was inhibited by caspase inhibitors
but not by ICAD. This finding agrees with ours and indi-
cates that there is a factor(s) distinct from CAD or caspases
that is responsible for nuclear morphological changes
during apoptosis. Purification and characterization of this
factor will be necessary to understand the mechanism and
physiological roles of the nuclear morphological changes
that accompany apoptosis.
Materials and methods
Assays for cell death and DNA fragmentation
Jurkat cells or transformants (JILdm) (2.5 × 105 cells/ml) expressing
caspase-resistant ICAD-L mutant were incubated at 37°C for various
periods of time with 10 µM staurosporine and cell death was
assayed by the WST-1 or Annexin V method, as described previously
[3]. To analyze the nucleosomal DNA fragmentation, 2.5 × 105 cells
were lysed by incubating at 37°C overnight with 0.2 mg/ml pro-
teinase K in 500 µl of 100 mM Tris-HCl pH 8.5, 5 mM EDTA,
200 mM NaCl and 0.2% SDS. DNA was then precipitated with 
isopropanol, treated with 0.1 mg/ml RNase A, and analyzed on a
1.5% agarose gel in 1 × TBE buffer.
Pulse-field gel electrophoresis
The pulse-field gel electrophoresis was carried out with Gene Naviga-
tor from Amersham-Pharmacia (Piscataway) according to the instruc-
tions provided by the supplier. In brief, 1 × 106 cells were suspended in
50 µl of ice-cold buffer A (10 mM Tris-HCl pH 8.0, 100 mM EDTA and
20 mM NaCl). The cell suspension was mixed with an equal volume of
1% low-melting point agarose (Amersham-Pharmacia) in buffer A,
transferred to wells of agarose blockformers and set at 4°C for 15 min.
Agarose blocks were removed form the blockformer and incubated
twice at 50°C for 24 h in 2 ml buffer A containing 1 mg/ml proteinase K
and 1% sarkosyl with gentle shaking. The blocks were then incubated
twice at 50°C for 1 h in 2 ml stop buffer (10 mM Tris-HCl pH 8.0, 1 mM
EDTA and 40 µg/ml PMSF). After washing with TE at 4°C, the blocks
were inserted into wells of a 1% agarose gel in 0.5 × TBE. Elec-
trophoresis was carried out at 200 V for 20 h with a 1–30 sec pulse
time using the interpolation mode. 
Electron microscopy
Cells were fixed with 2% glutaraldehyde, 2% paraformaldehyde in
phosphate-buffered saline for 2 h and post-fixed with 2% OsO4 for 1 h.
After block-staining with a 2% aqueous solution of uranyl acetate they
were dehydrated with ethanol in a graded series of concentrations and
embedded in Epon 812. Thin sections of the cells were prepared using
an ultramicrotome (Richert Ultracut N, Nissei); these were stained with
lead citrate and uranyl acetate and observed with a Hitachi H-7100
electron transmission microscope.
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Figure 2
Morphological changes of nuclei. (a–e) Jurkat cells and (f–j) JILdm
cells were treated at 37°C with 10 µM staurosporine for 0 h (a,f),
1 h (b,g), 2 h (c,h), and 3 h (d,e,i,j), and observed under an electron
transmission microscope. In (e,j), the cells were pre-incubated for 1 h
with 0.5 mM zVAD-fmk before treatment with staurosporine. The scale
bars represent 1.0 µm.
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